Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who struggle to take daily HIV pills may benefit from long-acting injectable ...

Let’s take your partner’s HIV status out of the equation for a moment. You’re looking at a person who has a concerning temper, refuses to admit faults (and, therefore, probably refuses to work on them ...

Philadelphia announced in 2020 that the city would be participating in an initiative to “end” the HIV epidemic by reducing ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

SAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

Without U.S. funding, distribution from the warehouse, which stocks all U.S. government-donated HIV medicine to Kenya, has ...

Source: Bringing HIV services to hard-to-reach people in Victoria Falls | UNAIDS When Desire speaks about his role as a peer ...

This research on a T-cell–targeting vaccines in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of ...

By Amanda Hari Click here for updates on this story SAN FRANCISCO (KPIX) — A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...